On the back of this momentum, I’m thrilled to host a panel of experts in a discussion of sustainability in manufacturing and development of delivery technologies and devices at the 2023 PODD. – Dr Monica Adams, GSK
NEW YORK (PRWEB)
August 03, 2023
The Conference Forum announced that the 13th annual PODD: Partnership Opportunities in Drug Delivery conference will feature sustainability as a main topic addressed throughout the agenda, October 16-17 at the Westin Copley Place, in Boston, MA.
“The biopharma and drug delivery industries are actively moving to embed sustainability into core principles, products, and processes,” said Dr Monica Adams, Head – Packaging, Device and Design Solutions, GSK. “On the back of this momentum, I’m thrilled to host a panel of experts in a discussion of sustainability in manufacturing and development of delivery technologies and devices at the 2023 PODD.”
“As many pharmaceutical companies commit to accelerate the delivery of net zero health systems and sustainable practices, it is imperative to feature perspectives on the implementation and implications for these initiatives,” said Andrew Goldstein, Producer of the PODD Conference.
The PODD 2023 conference featured sustainability sessions include:
Dr Marianne Ølholm, Senior Vice President, Devices and Delivery Solutions, Novo Nordisk, will join the PODD Conference as the Sustainability Keynote. Dr Ølholm will participate in a fireside discussion on Laying a Path for a More Sustainable Future in the Device R&D Space.
Rasmus Just, Vice President, Device Innovation, Novo Nordisk, will present a holistic approach to Integrating Sustainability in Device Development.
Dr Monica Adams, Head – Packaging, Device and Design Solutions, GSK, will moderate a panel discussion on Working Towards Sustainability in the Manufacturing and Development of Delivery Technology & Devices with perspectives from AstraZeneca, GSK, Novo Nordisk and Teva.
Nanoparticle engineering company, Nanoform will present a session called A Patient and Planet Centric Approach to Enabling Drug Delivery
Additional topic areas for PODD 2023 include: AI/ML and computational biology approaches to drug delivery, new approaches in CNS/PNS delivery, facilitating collaboration between formulation and device teams during combination product development, ophthalmic delivery, the future of digital technology in the connected device space, high-volume/high-concentration injectables and targeted delivery of gene editing technologies.
The PODD Conference fosters collaborations between pharmaceutical, biotech, and drug delivery companies to develop more effective therapies for patients, improve the patient experience of taking medicine and extend the life cycle of the medicine. With pharmaceutical companies committing to reduce emissions and decarbonize, the PODD conference will highlight cross-industry perspectives on integrating sustainability in the development of drug delivery technologies.
Pharmaceutical companies presenting include: Sanofi, Pfizer, AstraZeneca, Amgen, Eli Lilly & Company, Novo Nordisk, Chiesi USA, Genentech, Novartis, Takeda Pharmaceuticals, Roche, Gilead Sciences, GSK, Bristol Myers Squibb, Johnson & Johnson, AbbVie, Regeneron, Teva Pharmaceuticals, Ionis Pharmaceuticals, Voyager Therapeutics, Apellis Pharmaceuticals and Beam Therapeutics.
To learn more about the event, visit PODDConference.com
About the PODD: Partnership Opportunities in Drug Delivery Conference:
Pharma, biotech and the drug delivery industries gather annually at PODD to assess delivery needs, latest trends and information on deals and learn about a wide range of innovative drug delivery technologies that could improve the delivery of various types of drugs. This can include proteins, peptides, oligonucleotides, biologics, and small molecules and more. PODD provides business development opportunities through organized networking and a partnering tool for new, emerging and established collaborations.
About the Conference Forum:
The Conference Forum is a life science industry research firm that develops conferences, podcasts, newsletters and webinars primarily around how to get therapeutics to patients faster. They examine and challenge the complex ecosystem of drug development and delivery, bringing ideas together from a variety of sources to help advance clinical research with common goals that are patient-focused. They are committed to creating the best content, exchange of ideas and solutions among peers, as well as providing high-quality networking.
Learn more about the Conference Forum at theconferenceforum.org.
Share article on social media or email: